Counterfeit cancer drug hits U.S. shores, SEC probes Groupon, ethanol heads to the pumps, and more.
- After a Massey oil executive pled guilty to a conspiracy to defraud charge, the mining industry announced a new voluntary safety initiative. See related The Regulatory Review essay.
- The Securities and Exchange Commission (SEC) has reportedly initiated a preliminary investigation of Groupon’s financial results, after the online discount deal Web site revised its first earnings results since going public.
- Wall Street banks prepared to move some of their top traders into new units ahead of the impending Volcker Rule.
- The Environmental Protection Agency (EPA) approved the first applications for the distribution of gasoline that contains up to 15 percent ethanol.
- The U.S. Nuclear Regulatory Commission (NRC) chair announced plans to visit faulty San Onofre, California power plant.
- President Obama signed the Stop Trading on Congressional Knowledge Act, banning insider trading on Capitol Hill.
- A counterfeit version of the cancer drug Avastin hit U.S. markets for second time. See related The Regulatory Review essay.
- After the release of an inspector general report, General Services Administrator (GSA) Martha Johnson resigned over extravagant conference expenses.